1LundVJ.Malignant melanoma of the nasal cavity and paranasal sinu- ses.Ear Nose Throat J,1993,72(4):285-290. 被引量：1
2Regauer S, Anderhuber W, Richtig E, et al. Primary mucosal mela-nomas of the nasal cavity and paranasal sinuses. A clinicopathological analysis of 14 cases [J]. APMIS, 1998,106 (3) :403-410. 被引量：1
4Gogas H J, Kirkwood JM, Sondak VK. Chemotherapy for metastatic melanoma: time for a change [ J ] . Cancer, 2007,109(3):455-464. 被引量：1
5Atkins MB. Cytokine-based therapy and biochemotherapy for advanced melanoma [ J ] . Clin Cancer Res, 2006, 12(7):2353-2358. 被引量：1
6Khayat D, Bernard-Marly C, Meric JB, et al. Biochemotherapy for advanced melanoma: maybe it is real [ J ] . J Clin Oncol, 2002, 20 (10): 2411-2414 被引量：1
7Daponte A, Ascierto PA, Gravina A,et al. Cisplatin, dacarbazine, and fotemustine plus interferon alpha in patients with advanced malignant melanoma:a multicenter phase Ⅱ study of the Italian Cooperative Oncology Group [ J ] . Cancer,2000,89(12):2630-2636. 被引量：1
8O'rourke MG, Johnson MK, Lanagan CM, et al. Dendritic cell immunotherapy for stage Ⅳ melanoma [ J ] . Melanoma Res, 2007, 17(5):316-322. 被引量：1
9Dudley ME, Wunderlich JR, Robbins PF, et al. Cancer regression and autoimmunity in patients after clonal repopulation with antitumor lymphocytes [ J ] , Science, 2002, 298 ( 25 ) : 850-854. 被引量：1
10Hofmann MA, Sterry W, Trefzer U. Complex combination biochemotherapy regimen in advanced metastatic melanoma in a non-intensive care unit: toxicity or benefit [ J ] . Jpn J Clin Oncol, 2007,37(3):224-229. 被引量：1
